CClinicalTrials.gg
CompletedNCT03052959Updated Nov 1, 2021Results posted

BETTER HEALTH: Durham

An interventional study of Immediate Intervention and Wait List Intervention in Cancer and Chronic Disease Prevention, sponsored by Unity Health Toronto. Completed at 1 site in Canada. Open to participants aged 40 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-11-01.

Sponsored by Unity Health Toronto · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
40 Years to 64 Years
Sex
All
01

Study summary

The BETTER intervention consists of supportive meetings between a specially trained prevention practitioner nurse and individuals aged 40-64 years to review recommended chronic disease prevention and screening activities (CDPS). The prevention practitioner nurse will assist participants to identify goals for accomplishing CDPS activities in the next 6 months. Promotion, recruitment of participants and delivery of the BETTER intervention will be adapted to meet the needs of the residents through the use of participatory research methods and community engagement strategies. The study population consists of individuals aged 40-64 years living in 10 designated areas or "clusters" within Durham Region in Oshawa and Whitby.

Objectives:

  1. Help people in the designated areas identify personal goals related to chronic disease prevention and screening activities.
  2. Evaluate whether the prevention practitioner was effective in helping people achieve their goals and explore whether this type of intervention could work in other settings.
  3. Share what the investigators learn with government and other public health units in Ontario and across Canada.

Some clusters will receive the BETTER intervention right away and other clusters will be in a wait-list control group to receive the intervention 6 months later. Our main outcome is the change in a score that considers the number of preventive health items a person has achieved during the 6 months. The investigators will also be doing in-depth interviews and focus groups with health care providers, community organizations and people who live in the designated areas to understand whether the primary practitioner was effective.

Read the detailed description

Research has shown that many Ontarians do not participate in all the chronic disease prevention and screening activities that could keep them healthy. Previous studies have found that a prevention practitioner, a nurse who works with health care providers and their practices, can be effective at improving the uptake of chronic disease prevention and screening activities.

The goal of this study is to adapt the BETTER intervention from a health care setting with family practice teams to a community-based strategy in designated areas in Durham Region. The BETTER intervention consists of supportive meetings between a specially trained prevention practitioner nurse and individuals aged 40-64 years to review recommended chronic disease prevention and screening activities (CDPS). The prevention practitioner nurse will assist participants to identify goals for accomplishing CDPS activities in the next 6 months. Promotion, recruitment of participants and delivery of the BETTER intervention will be adapted to meet the needs of the residents through the use of participatory research methods and community engagement strategies.

Previous work by the researchers identified census dissemination areas in Ontario with: (1) the lowest quintile of median household income, (2) low cancer screening rates, and 3) poor access to primary care services. The study population consists of individuals aged 40-64 years living in 10 designated areas or "clusters" within Durham Region in Oshawa and Whitby. The investigators will be working closely with local community agencies and primary care providers to identify people who may benefit from this study.

Objectives:

  1. Help people in the designated areas identify personal goals related to chronic disease prevention and screening activities.
  2. Evaluate whether the prevention practitioner was effective in helping people achieve their goals and explore whether this type of intervention could work in other settings.
  3. Share what the investigators learn with government and other public health units in Ontario and across Canada.

Some clusters will receive the BETTER intervention right away and other clusters will be in a wait-list control group to receive the intervention 6 months later. The investigators will compare the two groups. The study will involve about 120 residents in 10 designated areas. Our main outcome is the change in a score that considers the number of preventive health items a person has achieved during the 6 months. The investigators will also be doing in-depth interviews and focus groups with health care providers, community organizations and people who live in the designated areas to understand whether the primary practitioner was effective.

02

Conditions studied

  • Cancer and Chronic Disease Prevention

Browse trials for

03

In context

Chronic Disease

990 studies on the registry are indexed under Chronic Disease; 178 are open to participants now.

This study's enrollment of 126 is close to the median of 120 across 722 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

Unity Health Toronto is the lead sponsor of 434 studies on the registry; 76 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Males and females aged 40 - 64 years living in sampled low income clusters in Durham region who are English speakers (including illiterate persons). Only one participant per residential household may participate.

Exclusion criteria

Exclusion Criteria:

  • Unable to provide informed consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
126 participants (actual)

Study arms

  • Experimental
    Immediate Intervention

    Behavioral: Immediate Intervention

  • Other
    Wait List Intervention

    Other: Wait List Intervention

Interventions

  • BehavioralImmediate Intervention

    The 'BETTER' prevention practitioner intervention involves assessment of a person's current participation, or lack of participation, among domains of evidence-based chronic disease prevention and surveillance (CDPS) actions. The assessment is followed several days later by a supportive meeting with a prevention practitioner nurse, using principles of shared decision making and health coaching, to establish goals for accomplishing CDPS activities of the individual's choice during the subsequent six months to develop personal goals and targets for participating in CDPS actions during the following six months. In BETTER HEALTH: DURHAM, the prevention practitioner nurse will be a public health nurse from the Durham Region Health Department.

  • OtherWait List Intervention

    The control arm will receive the prevention practitioner intervention 6 months after the intervention arm. Their outcomes will not be assessed in the study.

06

What researchers measure

Primary outcomes

  1. Composite Outcome Measure: Mean Percentage of CDPS Actions at Baseline That Are Subsequently Met at Follow-up

    The primary outcome measure is the mean percentage of the number of eligible CDPS actions at baseline that are subsequently met (by self-report) at follow-up, measured at the patient level. As a function of baseline characteristics, certain individuals are eligible for certain CDPS actions. At follow-up, each patient will be re-evaluated and the number of eligible actions met will be enumerated. Six months after the baseline survey interview, the research assistant will administer the outcome survey on health and CDPS actions to participants in intervention and control clusters alike. All outcomes are self-reports of the completion of CDPS actions.

    Time frame: Six months

Secondary outcomes

  1. Completion of Individual Actions

    The investigators will report the frequency with which individual CDPS actions were completed, for those actions for which the individual was eligible at baseline

    Time frame: Six months

  2. Number of Self-referrals

    The investigators will report the frequency with which self-referrals were reported to the prevention practitioner.

    Time frame: Six months

07

Results

Posted Nov 1, 2021
Limitations and caveats
Research coordinator administering survey to participants may have served as a co-intervention; relied exclusively on self-report; excluded non-English speakers; did not explore the role of other sociodemographic characteristics such as race/ethnicity and immigration status that may intersect with income; did not explicitly compare the clusters based on factors that may have affected uptake of recommendations, such as proximity to primary care or access to public transportation

Participant flow

Participant flow — Overall Study
MilestoneImmediate InterventionWait List Intervention
Started5966
Completed5561
Not completed45
Withdrew: Lost to follow-up45

Outcome measures

PrimaryComposite Outcome Measure: Mean Percentage of CDPS Actions at Baseline That Are Subsequently Met at Follow-up

The primary outcome measure is the mean percentage of the number of eligible CDPS actions at baseline that are subsequently met (by self-report) at follow-up, measured at the patient level. As a function of baseline characteristics, certain individuals are eligible for certain CDPS actions. At follow-up, each patient will be re-evaluated and the number of eligible actions met will be enumerated. Six months after the baseline survey interview, the research assistant will administer the outcome survey on health and CDPS actions to participants in intervention and control clusters alike. All outcomes are self-reports of the completion of CDPS actions.

Time frame:
Six months
Reported as:
Mean · percent of actions
Composite Outcome Measure: Mean Percentage of CDPS Actions at Baseline That Are Subsequently Met at Follow-up
percent of actionsImmediate InterventionWait List Intervention
Composite Outcome Measure: Mean Percentage of CDPS Actions at Baseline That Are Subsequently Met at Follow-up64.5 ± 27.542.1 ± 23.8
SecondaryCompletion of Individual Actions

The investigators will report the frequency with which individual CDPS actions were completed, for those actions for which the individual was eligible at baseline

Time frame:
Six months
Reported as:
Number · percentage of eligible actions
Completion of Individual Actions
percentage of eligible actionsImmediate InterventionWait List Intervention
Fasting blood sugar/A1C screen29.025.0
Blood pressure screen81.841.7
Blood pressure monitor66.766.7
LDL measured31.626.3
Breast screening500
Colorectal screening14.30
Cervical screening2511.1
Body mass index screening72.70
Waist circumference73.61.6
Weight control53.857.1
Referral for body mass index greater than 2576.946.9
Smoking cessation11.13.6
Smoking cessation referral59.332.1
Alcohol control66.752.4
Alcohol cessation referral409.5
Physical activity improved62.264.3
Physical activity referral71.141.1
Healthy diet score improved90.491.8
Nutrition referral67.329.5
SecondaryNumber of Self-referrals

The investigators will report the frequency with which self-referrals were reported to the prevention practitioner.

Time frame:
Six months
Reported as:
Number · percentage of eligible actions
Number of Self-referrals
percentage of eligible actionsImmediate InterventionWait List Intervention
Fasting blood sugar/A1C screen29.025.0
Blood pressure screen81.841.7
Blood pressure monitored66.766.7
LDL measured31.626.3
Breast cancer screening500
Colorectal cancer screening14.30
Cervical screening25.011.1
Weight control53.857.1
Referral for body mass index greater than 2576.946.9
Smoking cessation referral59.332.1
Alcohol cessation referral409.5
Physical activity referral71.141.1
Nutrition referral67.329.5

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Immediate Intervention0/59 (0%)0/59 (0%)0/59 (0%)
Wait List Intervention0/66 (0%)0/66 (0%)0/66 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Immediate InterventionWait List InterventionTotal
Mean54.5 ± 6.453.2 ± 6.653.8 ± 6.5
Sex: Female, Male
Sex: Female, Male(Participants)Immediate InterventionWait List InterventionTotal
Female213253
Male383472
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Immediate InterventionWait List InterventionTotal
Race/ethnicity — White5052102
Race/ethnicity — Other91423
08

Study locations

1 site
  • Durham Region Health Department
    Whitby, Ontario, Canada
09

References and documents

Publications

  • Lofters AK, O'Brien MA, Sutradhar R, Pinto AD, Baxter NN, Donnelly P, Elliott R, Glazier RH, Huizinga J, Kyle R, Manca D, Pietrusiak MA, Rabeneck L, Riordan B, Selby P, Sivayoganathan K, Snider C, Sopcak N, Thorpe K, Tinmouth J, Wall B, Zuo F, Grunfeld E, Paszat L. Building on existing tools to improve chronic disease prevention and screening in public health: a cluster randomized trial. BMC Public Health. 2021 Aug 3;21(1):1496. doi: 10.1186/s12889-021-11452-x. Erratum In: BMC Public Health. 2021 Sep 21;21(1):1714. doi: 10.1186/s12889-021-11700-0. PubMed 34344340 ↗
  • Paszat L, Sutradhar R, O'Brien MA, Lofters A, Pinto A, Selby P, Baxter N, Donnelly PD, Elliott R, Glazier RH, Kyle R, Manca D, Pietrusiak MA, Rabeneck L, Sopcak N, Tinmouth J, Wall B, Grunfeld E. BETTER HEALTH: Durham -- protocol for a cluster randomized trial of BETTER in community and public health settings. BMC Public Health. 2017 Sep 29;17(1):754. doi: 10.1186/s12889-017-4797-3. PubMed 28962558 ↗

Study documents

  • Study protocol · Jan 30, 2017
  • Statistical analysis plan · Jul 23, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 1, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03052959
Lead sponsor
Unity Health Toronto
Collaborators
Sunnybrook Health Sciences Centre, Durham Region Health Department, University of Toronto
Responsible party
Sponsor
First posted
Feb 14, 2017
Start date
Oct 2, 2017
Primary completion
Jan 28, 2020
Completion
Jan 28, 2020
Results posted
Nov 1, 2021
Last update
Nov 1, 2021

Study contacts

Lawrence Paszat
principal investigator · Sunnybrook Health Sciences Centre

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion